As we discussed in a previous post, MA must have its own launch strategy to ensure that it is capable of proactively addressing the scientific needs of the healthcare community in a manner that is both effective and compliant.
In addition to having a clear strategy, another key success factor is the timing of MA launch activities. In this post, I will share a general MA launch timeline. However, all launches are unique, with their own set of requirements, so in order to put together even a generic timeline I will need establish a scenario as the basis:
- The drug being launched is a relatively recent in-license from a smaller company with no MA group.
- The drug is in P3 testing, with results expected in 10 to 12 months and an NDA filing expected soon after.
- The company managing the MA support of launch has an existing MA function but no experience in the drug’s therapeutic area
- As a result, the current field force (MSLs) are not sufficient to support the new drug
When we consider launch, the work breaks down into four broad categories:
- Operational Infrastructure: This includes people, processes and technology needed to support the MA launch (and post-launch) activities
- Scientific Outreach: All activities required to educate the healthcare community about the therapeutic area, disease state and drug.
- Research: All activities with the goal of data generation.
- Internal Support: All activities in which MA assists other functions within the company.
For simplicity sake, I will consider each of these categories in four different time periods:
- -24 to -18 Months before Launch
- -18 to -12 Months before Launch
- -12 to -6 Months before Launch
- -6 Months to Launch
During each time period, I will attempt to highlight some of the key deliverables in all the categories that are relevant. Not all categories are relevant in all time periods.
-24 to -18 Months before Launch
During this period, the primary goal is to develop and gain approval for the MA Launch Strategy. Since our example demands a fair amount of operational infrastructure development, the budget and timing for the needed resources must be agreed upon in this period. In some companies the Launch Team has not yet been formed, and in those cases MA will need to work with commercial leadership to ensure that its’ initial plans are in alignment with the current best thinking of the launch.
Category | Key Activities and Deliverables in this Period | Comments |
Operational Infrastructure |
| |
Scientific Outreach |
| |
Research |
| |
Internal Support |
|
-18 to -12 Months before Launch
This is a critical period for planning and infrastructure development. We are assuming in our example the need to hire a new MSL team, and the bulk of this activity takes place this period as well.
Category | Key Activities and Deliverables in this Period | Comments |
Operational Infrastructure |
| |
Scientific Outreach |
| |
Research |
| |
Internal Support |
|
-12 to -6 Months before Launch
This is the period when the work of supporting the launch begins in earnest for MA.
Category | Key Activities and Deliverables in this Period | Comments |
Operational Infrastructure |
| |
Scientific Outreach |
|
|
Research |
| |
Internal Support |
|
-6 Months to Launch
Like the last period, this period is focused on the execution of the plans developed earlier. One critical role that MA should be playing during this period is providing feedback that they are hearing to the rest of the organization. MA is not a market research function, but the questions they receive is valuable information that the commercial organization may wish to know.
Category | Key Activities and Deliverables in this Period | Comments |
Operational Infrastructure |
| |
Scientific Outreach |
| |
Research |
| |
Internal Support |
|
Closing Thoughts
Different therapies can drive very different timetables. If the drug in question is a new formulation of an existing, well established product, very little specific work may need to be done and the whole process can begin and end in the 6 months prior to launch. If it is a novel new oncology treatment with a companion diagnostic, you may wish to move up the timelines on certain activities like IIS which may even start before approval.
I would like to hear about your experience at launch. Please leave a comment below.
[...] MA Launch Generic Timeline [...]
ReplyDelete